vaccines Oct 29, 2021 Innovent Biologics, NeoCura Biomedical Technology Partner on Bespoke Immunotherapy Trial in China Oct 28, 2021 Anixa Biosciences, Cleveland Clinic Studying if Vaccine Prevents Triple-Negative Breast Cancer Relapse Sep 18, 2021 Gritstone Advances Personalized, Off-the-Shelf Cancer Vaccine Studies in Molecularly Defined Groups Premium Sep 14, 2021 IO Biotech Studying Cancer Vaccine With Merck's Keytruda in Advanced Melanoma Patients Jul 2, 2021 Elicio Therapeutics Begins Phase I/II Trial of Vaccine Against KRAS-Driven Tumors May 11, 2021 BostonGene, Abramson Cancer Center to Collaborate on Immunotherapy Studies Mar 23, 2021 European Consortium Wins €6.9M Grant to Develop HPV16-Positive Cancer Vaccine Dec 15, 2020 Frame Therapeutics, eTheRNA Immunotherapies Win €1.9M Grant to Develop Kidney Cancer Vaccine Jul 18, 2019 Elios Therapeutics Phase IIb Personalized Vaccine Study Yields Positive Top-Line Results Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week: Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
